end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableCurrent,AccruedLiabilitiesCurrent,AccruedProfessionalFeesCurrent,AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment,AdditionalPaidInCapital,AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue,AllocatedShareBasedCompensationExpense,AmortizationOfFinancingCostsAndDiscounts,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,CapitalExpendituresIncurredButNotYetPaid,CashAndCashEquivalentsAtCarryingValue,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CommonStockDividendsPerShareDeclared,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,ConversionOfStockSharesConverted1,ConvertiblePreferredStockSharesIssuedUponConversion,CostsAndExpensesRelatedParty,DebtInstrumentCarryingAmount,DebtInstrumentIncreaseAccruedInterest,DebtInstrumentUnamortizedDiscount,DeferredOfferingCosts,Depreciation,DividendsCommonStockStock,DueToRelatedPartiesCurrentAndNoncurrent,EarningsPerShareBasicAndDiluted,EmployeeRelatedLiabilitiesCurrent,FairValueAdjustmentOfWarrants,FinancialLiabilitiesFairValueDisclosure,GainLossOnDispositionOfAssets1,GeneralAndAdministrativeExpense,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities,IncreaseDecreaseInDeferredCharges,IncreaseDecreaseInOtherOperatingAssets,IncreaseDecreaseInOtherOperatingLiabilities,IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets,InterestExpense,InterestExpenseDebt,InterestExpenseDebtExcludingAmortization,InterestPaidNet,InterestPayableCurrent,LeaseCost,LesseeOperatingLeaseLiabilityPaymentsDue,LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths,LesseeOperatingLeaseLiabilityPaymentsDueYearThree,LesseeOperatingLeaseLiabilityPaymentsDueYearTwo,LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermDebt,LongTermDebtCurrent,LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo,LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear,LongTermDebtNoncurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NonoperatingIncomeExpense,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseExpense,OtherAccruedLiabilitiesCurrent,OtherAssetsNoncurrent,OtherLiabilitiesCurrent,OtherLiabilitiesNoncurrent,OtherNonoperatingIncomeExpense,OtherPrepaidExpenseCurrent,OtherReceivablesNetCurrent,PaymentsForRepurchaseOfConvertiblePreferredStock,PaymentsOfStockIssuanceCosts,PaymentsToAcquirePropertyPlantAndEquipment,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PreferredStockValue,PrepaidExpenseAndOtherAssetsCurrent,PrepaidInsurance,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock,ProceedsFromStockOptionsExercised,ProfitLoss,PropertyPlantAndEquipmentGross,PropertyPlantAndEquipmentNet,ResearchAndDevelopmentExpense,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,ShareBasedCompensation,SharesOutstanding,StockholdersEquity,StockIssued1,StockIssuedDuringPeriodValueConversionOfConvertibleSecurities,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueStockOptionsExercised,StockRepurchasedDuringPeriodValue,TemporaryEquityCarryingAmountAttributableToParent,TemporaryEquityLiquidationPreference,TemporaryEquitySharesAuthorized,TemporaryEquitySharesIssued,TemporaryEquitySharesOutstanding,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,AccountsReceivableRelatedParties,AccretionAmortizationOfDiscountsAndPremiumsInvestments,AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AssetsFairValueDisclosure,AvailableForSaleSecuritiesDebtSecuritiesCurrent,AvailableForSaleSecuritiesDebtSecuritiesNoncurrent,ComprehensiveIncomeNetOfTax,DebtSecuritiesAvailableForSaleRealizedGain,DebtSecuritiesAvailableForSaleRealizedLoss,DeferredFederalIncomeTaxExpenseBenefit,DeferredStateAndLocalIncomeTaxExpenseBenefit,DeferredTaxAssetsGoodwillAndIntangibleAssets,DeferredTaxAssetsGross,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilities,DeferredTaxLiabilitiesPropertyPlantAndEquipment,EffectiveIncomeTaxRateContinuingOperations,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationNondeductibleExpense,EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment,EffectiveIncomeTaxRateReconciliationOtherAdjustments,EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes,ImpairmentOfInvestments,ImpairmentOfLongLivedAssetsHeldForUse,IncomeTaxExpenseBenefit,IncreaseDecreaseInAccountsReceivableRelatedParties,LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFive,LesseeOperatingLeaseLiabilityPaymentsDueYearFour,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour,LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree,MarketableSecuritiesCurrent,OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent,PaymentsOfFinancingCosts,PaymentsToAcquireMarketableSecurities,PrepaidRent,ProceedsFromIssuanceOfDebt,RevenueFromContractWithCustomerExcludingAssessedTax,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate,UnrecognizedTaxBenefits,ValuationAllowanceDeferredTaxAssetChangeInAmount
2021-06-30,2021-09-10,10-Q,"Omega Therapeutics, Inc.",OMGA,CIK0001850838,USD,1169000.0,7268000.0,122000.0,3108000.0,2634000.0,685000.0,685000.0,33000.0,,130046000.0,125297000.0,,122411000.0,122752000.0,,,0.001,175000000.0,4647035.0,4647035.0,5000.0,,34678733.0,384000.0,12000000.0,,194000.0,1585000.0,300000.0,0.0,0.0,-3.36,1094000.0,11000.0,663000.0,,3637000.0,,,,,,,190000.0,215000.0,182000.0,,58000.0,600000.0,7064000.0,2618000.0,1205000.0,1563000.0,1678000.0,21937000.0,130046000.0,11800000.0,11806000.0,3000000.0,6000000.0,6000000.0,,8806000.0,,,,-15410000.0,-205000.0,15205000.0,-15205000.0,800000.0,1617000.0,308000.0,363000.0,1331000.0,-4000.0,275000.0,40000.0,,,,,,,,,1301000.0,,,,,,7208000.0,4100000.0,11184000.0,341000.0,-95123000.0,,,-92484000.0,,,,118000.0,,200593000.0,199600000.0,132858564.0,131008559.0,131008559.0,4588500.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-10,10-Q,"Omega Therapeutics, Inc.",OMGA,CIK0001850838,USD,911000.0,8711000.0,1403000.0,3466000.0,333942000.0,1123000.0,1123000.0,,,243271000.0,238759000.0,,234275000.0,234616000.0,,,0.001,200000000.0,47768565.0,47768565.0,48000.0,,,473000.0,12000000.0,,15000.0,0.0,400000.0,,0.0,-0.57,1771000.0,970000.0,,,4459000.0,,,,,,,339000.0,363000.0,184000.0,,58000.0,600000.0,6225000.0,2618000.0,1205000.0,1563000.0,839000.0,22932000.0,243271000.0,14309000.0,11985000.0,4500000.0,6000000.0,6000000.0,0.0,7485000.0,,,,-18528000.0,-1307000.0,17221000.0,-17221000.0,800000.0,397000.0,386000.0,187000.0,1138000.0,2000.0,507000.0,367000.0,,,,0.001,10000000.0,0.0,0.0,0.0,4484000.0,2128000.0,,,,,7251000.0,3785000.0,12289000.0,341000.0,-113651000.0,,,220339000.0,,200594000.0,128112000.0,88000.0,,,,,,,32303540.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-12-31,2022-03-10,10-K,"Omega Therapeutics, Inc.",OMGA,CIK0001850838,USD,2109000.0,9475000.0,759000.0,3851000.0,335147000.0,3184000.0,3184000.0,93000.0,5476484.0,233333000.0,229286000.0,44000.0,186482000.0,186823000.0,163531000.0,,0.001,200000000.0,47793469.0,47793469.0,48000.0,,,1708000.0,20000000.0,31000.0,131000.0,0.0,1387000.0,,,-3.05,2545000.0,1310000.0,,3000.0,16603000.0,1040000.0,6379000.0,,156000.0,10000.0,2646000.0,910000.0,998000.0,740000.0,754000.0,31000.0,2600000.0,195864000.0,3013000.0,11766000.0,10711000.0,,32705000.0,233333000.0,11983000.0,19869000.0,,0.0,2500000.0,,19869000.0,261539000.0,-40399000.0,-57609000.0,-68280000.0,-2248000.0,66176000.0,-66032000.0,3300000.0,500000.0,101000.0,399000.0,853000.0,-28000.0,436000.0,264000.0,132000.0,3126000.0,1467000.0,0.001,10000000.0,0.0,0.0,,3702000.0,1500000.0,131238000.0,125500000.0,274000.0,-68280000.0,7456000.0,3605000.0,47865000.0,341000.0,-134505000.0,3184000.0,,200628000.0,200594000.0,,128112000.0,274000.0,,,,,,,22404058.0,257000.0,-25000.0,0.0,-62000.0,149709000.0,21600000.0,17300000.0,-68342000.0,0.0,0.0,125800000.0,123000000.0,152000.0,41391000.0,188000.0,34194000.0,120300000.0,5638000.0,528000.0,879000.0,41203000.0,188000.0,182000.0,0.0,0.21,-0.308,-0.009,0.03,0.001,0.076,0.0,0.0,0.0,257000.0,148290000.0,11205000.0,10879000.0,7500000.0,10000000.0,38845000.0,-62000.0,15000.0,38932000.0,825000.0,8000000.0,144000.0,0.0,0.8018,0.7673,0.0112,0.0,21000000.0
